
Real estate is a hot commodity these days, as consumers nationwide find themselves drawn into bidding wars that are pushing the price of limited single-family housing inventory ever higher, reported PYMNTS. Betting that the market will continue on that hallowed hot streak, Blackstone Group announced today (June 22) that it has agreed to buy Home Partners of America, a company that buys distressed single-family homes, restores them and then rents them out again to tenants. The price of that deal will be $6 billion and is expected to close later this year.
And while the Blackstone deal is notable for its size, it is not unique in the high-action real estate segment, which of late is drawing interest from established investors and ambitious entrepreneurs looking to cash in on a hot market. Home may be where the heart is, but it is also increasingly looking like where the opportunity is to widen the field of players.
Blackstone is not new to the real estate market. After the subprime financial crisis, the investment firm became known for buying up distressed single-family homes and renting them out through a firm called Invitation Homes. Blackstone has since phased out of the market and it no longer holds any shares in Invitation Homes, which has become the largest U.S. firm in this industry with 80,000 single-family homes for lease.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas